- Home
- PAVM
PAVM
PAVmed Inc.
as 06-20-2025 4:00pm EST
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 12.0M | IPO Year: | 2016 |
| Target Price: | $19.00 | AVG Volume (30 days): | 162.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.55 - $1.90 | Next Earning Date: | 08-11-2025 |
| Revenue: | $1,993,000 | Revenue Growth: | -33.92% |
| Revenue Growth (this year): | -95.01% | Revenue Growth (next year): | 455.63% |
Latest PAVmed Inc. News
PAVM Breaking Stock News: Dive into PAVM Ticker-Specific Updates for Smart Investing
PR Newswire
5 days ago
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test
TipRanks
19 days ago
PAVmed subsidiary Veris Health partners with Ohio State University cancer center
MT Newswires
20 days ago
Pavmed's Veris Health Signs Long-Term Partnership Deal With Ohio State University Hospital
PR Newswire
20 days ago
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PR Newswire
a month ago
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
GuruFocus.com
a month ago
PAVmed Inc (PAVM) Q1 2025 Earnings Call Highlights: Strategic Expansion and Financial Fortification
PR Newswire
a month ago
PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results
PR Newswire
a month ago
Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results
Compare PAVM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PAVM PAVmed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.